Sulfasalazine

Inflammatory Bowel Disease

Sulfasalazine is primarily used to treat mild to moderate ulcerative colitis. It helps reduce symptoms such as stomach pain, diarrhea, and rectal bleeding. It is also used as maintenance therapy to increase the time between flare-ups and prevent symptoms from returning.

Arthritis

This medication is used to treat rheumatoid arthritis in adults and polyarticular juvenile rheumatoid arthritis in children. It is typically prescribed when other medications, such as salicylates or nonsteroidal anti-inflammatory drugs (NSAIDs), have not provided enough relief. It helps reduce joint pain, swelling, and stiffness.

Other Uses

Sulfasalazine may also be used to manage other inflammatory conditions, including:

• Ankylosing spondylitis (a type of arthritis that affects the spine)
• Crohn's disease

Mechanism of Action

Sulfasalazine is a prodrug, which means it is converted into its active forms after it enters the body. When the medication reaches the colon, natural bacteria break it down into two main components: sulfapyridine and 5-aminosalicylic acid (also known as mesalamine).

The way this medication works depends on the condition being treated:

• Ulcerative Colitis: The 5-aminosalicylic acid component is believed to be the primary active part for treating inflammatory bowel disease. It works locally on the lining of the intestines to reduce inflammation, tissue damage, and diarrhea.
• Rheumatoid Arthritis and Ankylosing Spondylitis: The exact way sulfasalazine works for joint conditions is not fully understood. However, it is thought that the sulfapyridine component or the whole molecule helps reduce systemic inflammation and may modify the immune system's response to decrease joint pain and swelling.

By targeting these inflammatory processes, sulfasalazine helps manage symptoms and can help prevent flare-ups of chronic conditions. Because it takes time for the medication to affect the immune system, it may take several weeks of consistent use before the full benefits are felt for joint pain.

Common Side Effects

• Nausea and vomiting
• Stomach upset or loss of appetite
• Headache
• Dizziness
• Unusual tiredness
• Orange-yellow discoloration of the urine or skin, which is typically harmless

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following:

• Signs of infection, such as fever, chills, or a persistent sore throat
• Unusual bruising or bleeding
• Pale skin or yellowing of the eyes and skin
• Dark-colored urine
• Severe skin reactions, including rash, blistering, or peeling
• Swelling of the lymph nodes
• Changes in the amount of urine produced
• Persistent muscle or joint pain

Other Considerations

Sulfasalazine may cause a temporary reduction in sperm count and fertility in men. This effect is generally reversed once the medication is discontinued.

Serious Allergic and Skin Reactions

Sulfasalazine has been linked to rare but life-threatening skin conditions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. These reactions often begin with flu-like symptoms followed by a painful rash or blisters that spread. Treatment should be stopped immediately if a skin rash or other signs of hypersensitivity occur.

Blood and Liver Monitoring

Severe blood disorders, such as a significant drop in white blood cells (agranulocytosis) or red blood cells (aplastic anemia), have occurred during treatment. Fatalities have also been reported due to liver failure. Healthcare providers typically perform blood counts and liver function tests before starting the medication and at regular intervals during the first several months of therapy.

Contraindications

Sulfasalazine should not be used by individuals with the following conditions:

• Known hypersensitivity to sulfasalazine, its metabolites, sulfonamides (sulfa drugs), or salicylates (such as aspirin).
• Intestinal or urinary tract obstructions.
• Porphyria, as the drug may trigger a severe attack.

General Precautions

G6PD Deficiency: Patients with glucose-6-phosphate dehydrogenase deficiency are at a higher risk of developing hemolytic anemia while taking this medication.

Asthma and Allergies: Caution is advised for those with severe allergies or bronchial asthma.

Hydration: Maintaining adequate fluid intake is important to prevent the formation of crystals in the urine and potential kidney stones.

Discoloration: Sulfasalazine may cause the urine or skin to turn an orange-yellow color. This is generally harmless but can permanently stain soft contact lenses.

Folic Acid: This medication can interfere with the absorption of folic acid. Supplementation may be necessary, particularly for patients who are pregnant.

Pregnancy

Sulfasalazine should be used during pregnancy only if the potential benefits outweigh the potential risks. While human studies have not established a clear link to birth defects, the medication can interfere with the absorption of folic acid. Because folic acid is critical for fetal development, healthcare providers often recommend folic acid supplementation for pregnant individuals taking this drug.

Breastfeeding

Sulfasalazine and its metabolites are excreted in breast milk. Although many infants are not affected, there have been reports of bloody diarrhea or loose stools in breastfed infants whose mothers were taking the medication. Caution is advised, and nursing parents should discuss the risks with their healthcare provider.

Male Fertility

In men, sulfasalazine may cause a reversible reduction in sperm count and motility. This effect typically resolves after the medication is discontinued.

Available Forms

Sulfasalazine is administered orally and is available in the following forms:

• Tablets: These are standard immediate-release tablets taken by mouth.
• Delayed-release tablets: Also referred to as enteric-coated tablets, these are designed to resist breaking down in the stomach so the medication can be released in the intestines.
• Oral suspension: This is a liquid form of the medication for patients who may have difficulty swallowing solid tablets.

FDA Approval Status

Sulfasalazine was first approved by the U.S. Food and Drug Administration (FDA) in 1950. It is available as a generic drug and is produced by several manufacturers in both immediate-release and delayed-release (enteric-coated) tablet forms.

Approved Indications

The FDA has approved sulfasalazine for the following conditions:

• Ulcerative Colitis: It is indicated for the treatment of mild to moderate ulcerative colitis and as an additional therapy in severe cases. It is also used to increase the time between flare-ups (maintenance of remission).
• Rheumatoid Arthritis: It is approved for adults with rheumatoid arthritis who have not responded sufficiently to salicylates or other nonsteroidal anti-inflammatory drugs (NSAIDs).
• Juvenile Rheumatoid Arthritis: The delayed-release tablets are approved for children with polyarticular-course juvenile rheumatoid arthritis who did not respond well to other treatments.

Safety and Monitoring

There are no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) currently mandated by the FDA for sulfasalazine. However, regulatory labeling includes warnings about potential serious adverse effects, such as blood disorders, severe skin reactions, and liver or kidney damage. Healthcare providers are advised to perform regular blood tests and monitoring while a patient is using this medication.

Generic Availability

Sulfasalazine is widely available in generic form. Generic medications are generally less expensive than brand-name versions because they do not require the same initial research and marketing costs. Both the immediate-release and delayed-release (enteric-coated) tablets are available as generics.

Insurance and Coverage

Most health insurance plans, including Medicare and Medicaid, cover sulfasalazine because it is a standard treatment for inflammatory conditions. Your specific out-of-pocket cost will depend on your insurance plan's formulary, copayments, and deductibles.

Factors Affecting Price

The price of sulfasalazine can vary based on several factors:

• Pharmacy Choice: Prices may differ between retail pharmacies, mail-order services, and hospital pharmacies.
• Prescription Quantity: Buying a 90-day supply may sometimes offer a lower cost per tablet compared to a 30-day supply.
• Formulation: There may be slight price differences between the standard immediate-release tablets and the enteric-coated tablets designed to be easier on the stomach.